- Home
- AGM vs ARQT Comparison
AGM vs ARQT Comparison
Compare AGM & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGM
- ARQT
- Stock Information
- Founded
- AGM 1987
- ARQT 2016
- Country
- AGM United States
- ARQT United States
- Employees
- AGM N/A
- ARQT N/A
- Industry
- AGM Finance Companies
- ARQT Biotechnology: Pharmaceutical Preparations
- Sector
- AGM Finance
- ARQT Health Care
- Exchange
- AGM Nasdaq
- ARQT Nasdaq
- Market Cap
- AGM 2.1B
- ARQT 1.7B
- IPO Year
- AGM N/A
- ARQT 2020
- Fundamental
- Price
- AGM $188.13
- ARQT $13.82
- Analyst Decision
- AGM Hold
- ARQT Strong Buy
- Analyst Count
- AGM 1
- ARQT 6
- Target Price
- AGM $215.00
- ARQT $18.80
- AVG Volume (30 Days)
- AGM 186.7K
- ARQT 2.0M
- Earning Date
- AGM 08-04-2025
- ARQT 08-13-2025
- Dividend Yield
- AGM 3.19%
- ARQT N/A
- EPS Growth
- AGM N/A
- ARQT N/A
- EPS
- AGM 16.17
- ARQT N/A
- Revenue
- AGM $357,515,000.00
- ARQT $212,819,000.00
- Revenue This Year
- AGM $9.70
- ARQT $61.15
- Revenue Next Year
- AGM $8.26
- ARQT $37.98
- P/E Ratio
- AGM $11.64
- ARQT N/A
- Revenue Growth
- AGM N/A
- ARQT 100.03
- 52 Week Low
- AGM $159.64
- ARQT $7.86
- 52 Week High
- AGM $217.60
- ARQT $17.75
- Technical
- Relative Strength Index (RSI)
- AGM 50.93
- ARQT 50.73
- Support Level
- AGM $183.69
- ARQT $12.97
- Resistance Level
- AGM $190.00
- ARQT $13.84
- Average True Range (ATR)
- AGM 4.80
- ARQT 0.61
- MACD
- AGM -0.54
- ARQT 0.02
- Stochastic Oscillator
- AGM 40.44
- ARQT 51.64
About AGM Federal Agricultural Mortgage Corporation
Federal Agricultural Mortgage Corp provides agricultural real estate and rural housing mortgage loans in the secondary market in the U.S. Its operations consist of seven segments: Farm & Ranch, Corporate AgFinance, Power & Utilities, Broadband Infrastructure, Renewable Energy, Funding, and Investments. The company purchases eligible mortgage loans secured by first liens on agricultural real estate and rural housing under the Farm & Ranch line of business. Its subsidiary purchases portions of certain agricultural, rural development, business and industry, and community facilities loans guaranteed by the USDA.
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.